3-HYDROXYPYRUVIC ACID LITHIUM SALT
|
|
|
- CAS號:
- 209728-15-4
- 英文名:
- 3-Hydroxypyruvic Acid Lithium Salt
- 英文別名:
- Hydroxypyruvic acid lithium hydrate;3-Hydroxypyruvic acid lithium hydrate;β-Hydroxypyruvic acid lithium hydrate;β-Hydroxypyruvic acid lithium hydrate
- 中文名:
- 3-HYDROXYPYRUVIC ACID LITHIUM SALT
- 中文別名:
- 化合物 T19364
- CBNumber:
- CB58017360
- 分子式:
- C3H7LiO5
- 分子量:
- 130.02
- MOL File:
- 209728-15-4.mol
|
|
|
3-HYDROXYPYRUVIC ACID LITHIUM SALT化學(xué)性質(zhì)
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO (Slightly, Heated), Water (Slightly)
-
|
-
形態(tài):
-
Solid
-
|
-
顏色:
-
Off-White
-
|
3-HYDROXYPYRUVIC ACID LITHIUM SALT性質(zhì)、用途與生產(chǎn)工藝
Hydroxypyruvic acid lithium hydrate (β-Hydroxypyruvic acid lithium hydrate) 是甘氨酸、絲氨酸和蘇氨酸代謝的中間產(chǎn)物 (intermediate)。Hydroxypyruvic acid lithium hydrate 是絲氨酸-丙酮酸氨基轉(zhuǎn)移酶和乙醛酸還原酶/羥基丙酮酸還原酶的底物 (substrate)。Hydroxypyruvic acid lithium hydrate 參與了二甲基甘氨酸脫氫酶缺乏癥的代謝紊亂途徑。
IC50: intermediate; substrate
Hydroxypyruvic acid (lithium hydrate) (intravenous injection; 100 mg/ml; slowly over 10 min) increases the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) in control rats, in addition, it increases to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats.
3-HYDROXYPYRUVIC ACID LITHIUM SALT
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
|---|
| 2023/03/20 | HY-113013A | 3-HYDROXYPYRUVIC ACID LITHIUM SALT
Hydroxypyruvic acid lithium hydrate | 209728-15-4 | 1mg | 1800元 |
| 2023/03/20 | HY-113013A | 3-HYDROXYPYRUVIC ACID LITHIUM SALT
Hydroxypyruvic acid lithium hydrate | 209728-15-4 | 5mg | 5400元 |
3-HYDROXYPYRUVIC ACID LITHIUM SALT
生產(chǎn)廠家
209728-15-4, 3-HYDROXYPYRUVIC ACID LITHIUM SALT 相關(guān)搜索:
- 化合物 T19364
- 209728-15-4
- 3-Hydroxypyruvic acid lithium hydrate
- Hydroxypyruvic acid lithium hydrate
- β-Hydroxypyruvic acid lithium hydrate
- β-Hydroxypyruvic acid lithium hydrate